Sandbox c12
From Proteopedia
(Difference between revisions)
(16 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <Structure load='1acj' size=' | + | <Structure load='1acj' size='500' frame='true' align='right' caption='TcAChE' /> |
+ | |||
1ACJ shows the crystal structure of Torpedo californica acetylcholinesterase (TcAChE) complexed with tacrine. | 1ACJ shows the crystal structure of Torpedo californica acetylcholinesterase (TcAChE) complexed with tacrine. | ||
Line 6: | Line 7: | ||
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease. | It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease. | ||
- | + | <scene name='User:Jaime_Prilusky/How_do_we_get_the_oxygen_we_breathe/Heme/1'>attached to the Fe</scene> | |
- | + | <scene name='Sandbox_c12/Label/1'>Tacrines ring</scene> is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c12/Residuos_84_y_330/1'>W84 and F330</scene>)<ref>pmid 8415649</ref> | |
+ | |||
+ | <references/> |
Current revision
|
1ACJ shows the crystal structure of Torpedo californica acetylcholinesterase (TcAChE) complexed with tacrine.
Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor.
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 ()[1]